Mark Russom

Mark Russom is an experienced pharmaceutical professional with a robust background in market access and sales leadership. Currently serving as Senior Director of Market Access at Intra-Cellular Therapies since September 2019, Mark leads the development and execution of strategies for engagement across US payer channels. Previously, as Vice President of Sales at Amas Pharmaceuticals from 2018 to 2019, Mark was responsible for establishing and directing the sales strategy of a start-up pharmaceutical wholesaler. Mark's extensive tenure at Eli Lilly and Company from 1990 to 2017 included senior leadership roles in managed markets, where Mark built and led high-performing commercial teams. Mark holds a Bachelor of Science in Pharmacy from The University of Georgia and an MBA from the University of Tampa's John H. Sykes College of Business.